TIAA CREF Investment Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.64M	Buy	227,358 +670	+0.3%	+$4.85K	﹤0.01%	2096
2018 Q4	$1.68M	Buy	226,688 +2,009	+0.9%	+$12.7K	﹤0.01%	2049
2018 Q3	$1.22M	Sell	224,679 -95,083	-30%	-$408K	﹤0.01%	2354
2018 Q2	$1.14M	Buy	319,762 +71,920	+29%	+$200K	﹤0.01%	2441
2018 Q1	$508K	Buy	247,842 +7,897	+3%	+$20.5K	﹤0.01%	2725
2017 Q4	$633K	Sell	239,945 -10,806	-4%	-$37.8K	﹤0.01%	2669
2017 Q3	$1.32M	Buy	250,751 +30,890	+14%	+$133K	﹤0.01%	2387
2017 Q2	$783K	Buy	219,861 +9,062	+4%	+$36.5K	﹤0.01%	2663
2017 Q1	$1.09M	Sell	210,799 -15,752	-7%	-$77.1K	﹤0.01%	2471
2016 Q4	$861K	Sell	226,551 -8,234	-4%	-$59.8K	﹤0.01%	2625
2016 Q3	$2.1K	Sell	234,785 -6,341	-3%	-$53K	﹤0.01%	2146
2016 Q2	$1.7M	Buy	241,126 +31,766	+15%	+$290K	﹤0.01%	2228
2016 Q1	$1.78M	Buy	209,360 +712	+0.3%	+$7K	﹤0.01%	2141
2015 Q4	$2.74M	Sell	208,648 -8,495	-4%	-$76.2K	﹤0.01%	1975
2015 Q3	$795K	Hold	217,143	–	–	﹤0.01%	2708
2015 Q2	$1.25M	Buy	217,143 +13,260	+7%	+$76.7K	﹤0.01%	2579
2015 Q1	$1.19M	Sell	203,883 -3,619	-2%	-$25K	﹤0.01%	2522
2014 Q4	$1.63M	Sell	207,502 -30,640	-13%	-$196K	﹤0.01%	2372
2014 Q3	$1.17M	Sell	238,142 -66,641	-22%	-$348K	﹤0.01%	2546
2014 Q2	$1.88M	Buy	304,783 +72,620	+31%	+$363K	﹤0.01%	2332
2014 Q1	$1.24M	Sell	232,163 -6,690	-3%	-$42.3K	﹤0.01%	2519
2013 Q4	$1.25M	Buy	238,853 +24,300	+11%	+$112K	﹤0.01%	2537
2013 Q3	$1.19M	Buy	214,553 +6,753	+3%	+$23.4K	﹤0.01%	2517
2013 Q2	$524K	Buy	+207,800	New	+$517K	﹤0.01%	2923

Other funds holding PACB